학술논문

Body mass index trajectories in young adulthood predict non‐alcoholic fatty liver disease in middle age: The CARDIA cohort study
Document Type
article
Source
Liver International. 38(4)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Cardiovascular
Heart Disease
Nutrition
Clinical Research
Liver Disease
Heart Disease - Coronary Heart Disease
Prevention
Obesity
Digestive Diseases
Chronic Liver Disease and Cirrhosis
3.1 Primary prevention interventions to modify behaviours or promote wellbeing
Prevention of disease and conditions
and promotion of well-being
Metabolic and endocrine
Oral and gastrointestinal
Good Health and Well Being
Adolescent
Adult
Body Mass Index
Female
Humans
Liver
Logistic Models
Longitudinal Studies
Male
Middle Aged
Multivariate Analysis
Non-alcoholic Fatty Liver Disease
Overweight
Prevalence
Prospective Studies
Risk Factors
Tomography
X-Ray Computed
United States
Young Adult
NAFLD
NASH
obesity
prevention
Gastroenterology & Hepatology
Clinical sciences
Language
Abstract
Background & aimsNon-alcoholic fatty liver disease is an epidemic. Identifying modifiable risk factors for non-alcoholic fatty liver disease development is essential to design effective prevention programmes. We tested whether 25-year patterns of body mass index change are associated with midlife non-alcoholic fatty liver disease.MethodsIn all, 4423 participants from Coronary Artery Risk Development in Young Adults, a prospective population-based biracial cohort (age 18-30), underwent body mass index measurement at baseline (1985-1986) and 3 or more times over 25 years. At Year 25, 3115 had liver fat assessed by non-contrast computed tomography. Non-alcoholic fatty liver disease was defined as liver attenuation ≤40 Hounsfield Units after exclusions. Latent mixture modelling identified 25-year trajectories in body mass index per cent change (%Δ) from baseline.ResultsWe identified four distinct trajectories of BMI%Δ: stable (26.2% of cohort, 25-year BMI %Δ = 3.1%), moderate increase (46.0%, BMI%Δ = 21.7%), high increase (20.9%, BMI%Δ = 41.9%) and extreme increase (6.9%, BMI%Δ = 65.9%). Y25 non-alcoholic fatty liver disease prevalence was higher in groups with greater BMI %Δ: 4.1%, 9.3%, 13.0%, and 17.6%, respectively (P-trend